Supporting Sponsors

We pioneered and built one of the first specialty medical technology executive search firms in the U.S. and have been identifying, assessing, and placing outstanding executives for more than 30 years. In rapidly emerging markets, we believe that great leadership transforms people and organizations. We have earned a reputation for understanding company cultures and exceeding our clients’ expectations with expert assessment and insight. Not only are we seasoned consultants and executive recruiters, we have also held leadership positions in healthcare start-ups and global firms delivering new medical technologies and novel solutions to patients.

MCRA is the leading industry-specialized CRO and integrated advisory firm that assists clients through the entire technology life cycle, from strategic planning through commercialization. MCRA's regulatory team, which includes many former FDA officials with combined agency and industry experience in the areas of cardiovascular, orthopedics, neurology, digital health and in-vitro diagnostics, provides best in class regulatory support.  MCRA's reimbursement team works with many early-stage companies to define and execute successful US reimbursement and market access strategies.  MCRA's CRO can fully execute clinical studies or provide support to companies as they take lead in study execution.  The MCRA team provides services to a wide range of organizations in the healthcare industry, including start-ups to the world's leading healthcare organizations.  The full suite of integrated advisory services helps augment internal capabilities and processes, as well as ensure the ability to overcome regulatory and reimbursement hurdles.

Our life science practice group counsels the companies driving innovation to improve human health. We provide sophisticated counsel to medical device, pharmaceutical, and biotechnology companies at all stages of development, from early-stage entrepreneurial ventures through mature, global public companies. For the past ten years, Stradling has been selected as one of California’s leading life science law firms by Chambers & Partners, the premier ranking source for law firms and attorneys. Our life science team works with our employment, tax, litigation, real estate, intellectual property and mergers and acquisitions groups to provide the full spectrum of legal services to all of our clients.

As influencers who share over 100 years of experience ingrained in the Healthtech industry and three decades of publicity and media outreach, we influence at the point you need it most. With limitless capabilities and resources across our sister companies, TMG360 Media integrates unparalleled access to industry decision-makers, a 4,000 sq ft. production studio, a team of dedicated Medtech publicists, and exclusive editorial coverage to influence mainstream media, policymakers, emerging companies, strategics, investors, payors and providers, clinicians, and consumers to look to your organization as the market leader.

When media meets Medtech, the opportunities to move health forward are limitless.

Three Bridges M&C is a global medtech business development firm providing a comprehensive list of services to help startup and SMEs to identify business weaknesses/challenges and determine relevant solutions in order to create value and sustainable growth. Our team combines decades of experience with focus over innovations for clinicians and patients around the world. We have developed, driven regulatory approvals and commercialized globally a multitude of medical innovative technologies

Recognized for high-quality life sciences and health care solutions, Canada is home to a large pool of highly skilled life sciences professionals with a broad range of expertise. Canada offers an innovative environment for life sciences companies, with first-rate academic institutions, wide-reaching research networks, numerous partnership opportunities and low costs. Companies of any size that invest in research and development (R&D) in Canada can take advantage of the Scientific Research and Experimental Development (SR&ED) tax incentive program, Canada’s largest R&D program.

Access Strategy Partners Inc (ASPI) is a Healthcare Account Management and Strategy firm.  We accelerate successful market access into leading healthcare providers and supply chain organizations to drive new revenue for young medical companies with leading-edge technologies.

Founded in 2016, KoreConX is the first secure, All-In-One platform that manages private companies' capital market activity and stakeholder communications. With an innovative approach and to ensure compliance with securities regulations and corporate law, KoreConX offers a single environment to connect companies to the capital markets and now secondary markets. Additionally, investors, broker-dealers, law firms, accountants and investor acquisition firms, all leverage our eco-system solution. For investor relations and fundraising, the platform enables private companies to share and manage corporate records and investments: it assists with portfolio management, capitalization table and shareholder management, virtual minute book, security registration, transfer agent services, and virtual deal rooms for raising capital. The All-In-One platform manages the full life cycle of digital securities, including their issuance, trading, clearing, settlement, management, reporting, corporate actions, and custodianship.

Knobbe Martens is an agent of innovation, providing clients worldwide with forward-focused intellectual property and technology law service and representation. We are one of the largest and fastest-growing IP law firms, with over 275 attorneys and scientists representing the complete spectrum of technologies and IP practice areas.

We combine unmatched technical and litigation expertise to deliver superior results in both transactional and contested matters, for both cutting-edge start-ups and established Fortune 500 companies. Our work spans fields ranging from physics to pharmaceuticals and entertainment to engineering.

At PRIA Healthcare, we believe patients deserve to have access to—and insurance coverage for—the most innovative and scientifically proven medical devices, treatments, and procedures so they can receive the care their health and well-being depend on.

Leonhardt Ventures LLC since 1982 has been developing medtech and biotech innovations. The team developed and patented the leading stent graft for aortic aneurysm repair and one of the leading percutaneous heart valve TAVR systems. They led the first non-surgical muscle stem cell repair of a human heart in the early 2000's. Since 2000 the focus has been on the convergence of bioelectrics and biologics for organ regeneration and healing in the areas of Heart & Cardiovascular, Brain, Aesthetics, Major Organ Regeneration and Cancer. Over 600,000 patients have been treated with Leonhardt inventions to date. Leonhardt has over 800 patent claims in the area of organ regeneration, recovery and support https://patents.justia.com/inventor/howard-j-leonhardt.  Leonhardt's Launchpads their innovation and startup launch accelerator arm with an R&D Lab in Irvine, California has over 30 startups/LTPs in its 2022 portfolio class all based on bioelectric and biologics based healing via a common core IP and technology platform just directed to different organs. 

Octane is the convening organization of the Southern California technology and medical technology business ecosystem by connecting people, resources and capital.  We will create 55,000 high paying technology jobs to Southern California by 2030 through our accelerator LaunchPad SBDC as well as our platform Octane Enterprise Solutions (OES). In addition, Octane hosts dozens of programs throughout the year and has direct access to capital.

Regulation D Resources ("RDR") was formed in 1999 to provide SEC Filing and Private Placement Offering preparation and execution support services to entrepreneurs and growing private companies.

Headquartered in Lakewood, Colorado, RDR is one of the leading Regulation D, Regulation CF, and Regulation A+ filing preparation service providers in the United States with a comprehensive matrix of services that spans transaction structuring, offering preparation, assistance with SEC and State securities compliance, and access to the capital markets through RDR's broker-dealer relationships and FINRA broker-dealer resources.

Since 1999, RDR has assisted in the preparation of over 5,000 private placement offering transactions. The foundation of our company and services is predicted on one simple mission statement:

"Provide superior services to entrepreneurs and business professionals for the creation and execuation of Regulation D, Regulation CF, and Regulation A+ exempt offerings to aggregate private capital."

RDR has also been active in lobbying for changes in SEC regulations to enable issuers to execute offerings more effectively. Starting in 2002, RDR began lobbying for changes to the general solicitation statutes to allow issuers to engage in open solicitation of a Regulation D offering. The resulting 506(c) exemption created under the JOBS Act of 2012 was very similar to proposed changes RDR supported ten years earlier. RDR was also very supportive of the changes to the Regulation A program and the creation of the improved Regulation A+ and Regulation CF progrms.

Rialto Markets is a trusted ‘go to’ fully regulated broker dealer empowering companies to raise money through unrivalled expertise in crowdfunding and institutional investment.

Rialto Markets operate a fully compliant and unique secondary market trading platform for buying and selling shares in private companies.

Rialto Markets is a SEC and FINRA Regulated Broker Dealer (Rialto Primary) operating an Alternative Trading System (Rialto Secondary) for private securities including those issued as a Digital Asset Security. Rialto Primary supports companies issuing equity and debt securities through Reg A+, Reg CF, and Reg D exemptions. Rialto Markets is registered in all 50 states including those requiring a broker dealer to issue Reg A+ securities.

Dash provides Development as a Service (DaaS) for more than 10 years, focusing on MedTech startup companies. Dash delivers programming and coding on a project basis that connects AI+ML+Data Science to apps, websites, existing products and future concepts. Dash is ISO 9001 certified company and No.1 fasted growing private company in Columbus OH recognized by Inc 500 magazine.